Choice of full-length spike protein by competing companies as sole Covid vaccine target reveals bioweapon operation: Yeadon

Playback speed

Share post at current time

0:00

Paid episode

The full episode is only available to paid subscribers of James Hill MD’s Newsletter

Choice of full-length spike protein by competing companies as sole Covid vaccine target reveals bioweapon operation: Yeadon

There could be no worse jab antigen pick: toxic, rapidly mutating to escape vaccinal immunity, and having humanlike protein sequences to provoke autoimmunity, says Pfizer ex-boss (Updated 6/25/22)

James Hill, MD

Jun 16, 2022

∙ Paid

In a video interview, Pfizer’s former respiratory medicine chief Michael Yeadon PhD decries singular use of the SARS-CoV-2 viral spike protein for Covid vaccines as highly toxic, rapidly mutating to …

The full video is for paid subscribers

Or purchase a paid subscription.